Oncotelic Therapeutics, Inc.
public$OTLC View Live Feed →
Total Raised
--
Contracts
--
Patents
--
PAC Giving
--
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
No recent news or market intelligence found for this entity.
Congressional Trades in $OTLC
No disclosed congressional trades found in $OTLC.
Insider Trades (Form 4)
GRANTDirector
KING STEVEN W
250 shares Jul 21, 2026
GRANTDIRECTOR AND CMO - TRANS. MED.
MAIDA ANTHONY E III
1,500 shares Jul 14, 2026
GRANTCBO
Saund Saran
1,500 shares Jul 14, 2026
GRANTCFO
Shah Amit B.
1,500 shares Jul 14, 2026
GRANTCHAIRMAN AND CEO
Trieu Vuong
2,000 shares Jul 14, 2026
BUYCHAIRMAN AND CEO
Trieu Vuong
$11,475255,000 shares Jun 25, 2026
BUYCHAIRMAN AND CEO
Trieu Vuong
$15,013335,759 shares Jun 17, 2026
Key People
Shah Amit B
CFO
Insider
Saund Saran
CBO
Insider
MAIDA ANTHONY E
DIRECTOR AND CMO - TRANS. MED.
BoardInsider
KING STEVEN W
Director
BoardInsider
Trieu Vuong
CHAIRMAN AND CEO
BoardInsider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro